Schizophrenia, Diabetes and Cognition

Back to Non-Medication Clinical Trials 

The prevalence of diabetes in schizophrenia is not only significantly higher than in the general American population, the rate of growth of new cases of diabetes is significantly faster as well. While serious physical consequences of diabetes are well-documented, the noteworthy cognitive effects of diabetes are less-known. It is important to determine if diabetes is associated with additional cognitive difficulties in patients with schizophrenia. These cognitive difficulties may have implications for both functioning independently as well as the cost and complexity of medical and psychiatric care that patients require. The purpose of this study is to describe how well patients who have both schizophrenia and diabetes perform on a series of cognitive tests in order to increase our understanding and to improve treatment of both disorders.

Participants will answer questions about their general health status and complete a series of paper and pencil cognitive tasks and one computerized attention test. The study takes approximately two hours. Research participants will be compensated for their time, and transportation is provided, if needed.

We are currently recruiting volunteers to serve as research participants primarily from the Maryland Psychiatric Research Center, Baltimore Veterans Administration and University of Maryland community psychiatry programs.

If you would be interested in participation or would like more information, please call Sharon August, MA at 410-402-6057 or email saugust@mprc.umaryland.edu.